CTNNB1 and breast lobular carcinoma: Therefore, although pathway analysis connected BCL9 and PYGO2 protein to the “beta-catenin:TCF transactivating complex,” it is possible that those proteins play a special role in beta-catenin-independent signaling pathway both in ductal and lobular carcinomas.